These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11707522)

  • 1. PML bodies associate specifically with the MHC gene cluster in interphase nuclei.
    Shiels C; Islam SA; Vatcheva R; Sasieni P; Sternberg MJ; Freemont PS; Sheer D
    J Cell Sci; 2001 Oct; 114(Pt 20):3705-16. PubMed ID: 11707522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interaction of PML bodies with the TP53 locus in Jurkat interphase nuclei.
    Sun Y; Durrin LK; Krontiris TG
    Genomics; 2003 Aug; 82(2):250-2. PubMed ID: 12837275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions.
    Wang J; Shiels C; Sasieni P; Wu PJ; Islam SA; Freemont PS; Sheer D
    J Cell Biol; 2004 Feb; 164(4):515-26. PubMed ID: 14970191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components.
    Grande MA; van der Kraan I; van Steensel B; Schul W; de Thé H; van der Voort HT; de Jong L; van Driel R
    J Cell Biochem; 1996 Dec; 63(3):280-91. PubMed ID: 8913879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells.
    Kiesslich A; von Mikecz A; Hemmerich P
    J Struct Biol; 2002; 140(1-3):167-79. PubMed ID: 12490165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promyelocytic leukemia nuclear body: sites of activity?
    Eskiw CH; Bazett-Jones DP
    Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML promotes MHC class II gene expression by stabilizing the class II transactivator.
    Ulbricht T; Alzrigat M; Horch A; Reuter N; von Mikecz A; Steimle V; Schmitt E; Krämer OH; Stamminger T; Hemmerich P
    J Cell Biol; 2012 Oct; 199(1):49-63. PubMed ID: 23007646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
    Carlile GW; Tatton WG; Borden KL
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):691-6. PubMed ID: 9794812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
    Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
    Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
    Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.
    Muratani M; Gerlich D; Janicki SM; Gebhard M; Eils R; Spector DL
    Nat Cell Biol; 2002 Feb; 4(2):106-10. PubMed ID: 11753375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not.
    Wiesmeijer K; Molenaar C; Bekeer IM; Tanke HJ; Dirks RW
    J Struct Biol; 2002; 140(1-3):180-8. PubMed ID: 12490166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SUMO-1-modified PML in nuclear body formation.
    Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
    Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of PML nuclear bodies increases in early S phase by a fission mechanism.
    Dellaire G; Ching RW; Dehghani H; Ren Y; Bazett-Jones DP
    J Cell Sci; 2006 Mar; 119(Pt 6):1026-33. PubMed ID: 16492708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
    Rasheed ZA; Saleem A; Ravee Y; Pandolfi PP; Rubin EH
    Exp Cell Res; 2002 Jul; 277(2):152-60. PubMed ID: 12083797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.